The pressence of macromolecular vasoactive intestinal polypeptide (VIP) in VIP-producing tumors. - Suppr | 超能文献

The pressence of macromolecular vasoactive intestinal polypeptide (VIP) in VIP-producing tumors.

作者信息

Yamaguchi K, Abe K, Miyakawa S, Ohnami S, Sakagami M, Yanaihara N

出版信息

Gastroenterology. 1980 Oct;79(4):687-94.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The pressence of macromolecular vasoactive intestinal polypeptide (VIP) in VIP-producing tumors.

Gastroenterology. 1980 Oct;79(4):687-94.

2

[WDHA syndrome (watery diarrhea, hypokalemia and achlorhydria) with high VIP contents in the blood and tumor tissue--a case study].[WDHA综合征（水样腹泻、低钾血症和无胃酸）伴血液和肿瘤组织中血管活性肠肽含量升高——病例研究]

Nihon Rinsho. 1978;36(3):656-62.

3

Molecular variants of vasoactive intestinal peptide in human colonic mucosa [proceedings].

J Physiol. 1978 Mar;276:55P-56P.

4

[Vasoactive intestinal polypeptide (VIP) tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay (author's transl)].[通过放射免疫测定法和放射受体测定法测量大鼠血管活性肠肽（VIP）的组织分布（作者译）]

Ann Endocrinol (Paris). 1977 Mar-Apr;38(2):145-6.

5

Ontogeny and immunoreactive forms of vasoactive intestinal peptide (VIP) in rat brain.大鼠脑中血管活性肠肽（VIP）的个体发生及免疫反应形式

Acta Endocrinol (Copenh). 1980 Apr;93(4):479-87. doi: 10.1530/acta.0.0930479.

6

Vasoactive intestinal peptide: quantification by radioimmunoassay in isolated cells, mucosa, and muscle of the hamster intestine.

Gastroenterology. 1978 Apr;74(4):718-21.

7

[Verner-Morrison syndrome (1 case with determination of vasoactive intestinal peptide (V.I.P.) and electron microscope study)].

Lille Med. 1979 Mar;24(3):189-93.

8

Isolation and amino acid composition of human vasoactive intestinal polypeptide (VIP).人血管活性肠肽（VIP）的分离及氨基酸组成

Horm Metab Res. 1982 Jan;14(1):28-9. doi: 10.1055/s-2007-1018912.

9

VIP measurement in distinguishing Verner-Morrison syndrome and pseudo Verner-Morrison syndrome.血管活性肠肽测量在鉴别韦纳-莫里森综合征和假性韦纳-莫里森综合征中的应用

Clin Endocrinol (Oxf). 1976;5 Suppl:223S-228S. doi: 10.1111/j.1365-2265.1976.tb03831.x.

10

[Vasoactive intestinal polypeptide (VIP)--new radioimmunoassay and its possible clinical applications].[血管活性肠肽（VIP）——新的放射免疫测定法及其可能的临床应用]

Schweiz Med Wochenschr. 1986 Jul 19;116(29):985-6.

引用本文的文献

1

Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas).分泌血管活性肠肽的胰腺和神经节神经母细胞瘤（血管活性肠肽瘤）的临床病理研究

Br Med J (Clin Res Ed). 1981 May 30;282(6278):1767-71. doi: 10.1136/bmj.282.6278.1767.

2

Peptide hormone production by adenocarcinomas of the lung; its morphologic basis and histogenetic considerations.肺腺癌产生的肽类激素；其形态学基础及组织发生学思考。

Virchows Arch A Pathol Anat Histopathol. 1983;400(3):245-57. doi: 10.1007/BF00612186.

3

Multiple forms of gastroenteropancreatic hormones.多种胃肠胰激素形式。

Gut. 1981 Dec;22(12):1048-69. doi: 10.1136/gut.22.12.1048.

4

Pancreatic endocrine tumours associated with WDHA syndrome. An immunohistochemical and electron microscopic study.

Virchows Arch A Pathol Anat Histopathol. 1985;405(3):311-23. doi: 10.1007/BF00710067.